Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · IEX Real-Time Price · USD
9.15
+0.09 (0.99%)
At close: Apr 26, 2024, 4:00 PM
9.33
+0.18 (1.97%)
After-hours: Apr 26, 2024, 7:12 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $1.45 billion as of April 26, 2024.
Market Cap
1.45B
Enterprise Value
1.00B
1-Year Change
n/a
Ranking
Category
Stock Price
$9.15
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $1.45B, a decrease of -43.72%. That is a compound annual growth rate of -60.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 1.45B | 0.99% |
Apr 25, 2024 | 1.44B | -5.53% |
Apr 24, 2024 | 1.52B | -6.89% |
Apr 23, 2024 | 1.64B | -1.06% |
Apr 22, 2024 | 1.65B | 2.26% |
Apr 19, 2024 | 1.62B | -3.50% |
Apr 18, 2024 | 1.68B | 0.76% |
Apr 17, 2024 | 1.66B | -4.47% |
Apr 16, 2024 | 1.74B | -2.05% |
Apr 15, 2024 | 1.78B | -17.48% |
Apr 12, 2024 | 2.15B | -3.21% |
Apr 11, 2024 | 2.23B | -4.50% |
Apr 10, 2024 | 2.33B | 0.90% |
Apr 9, 2024 | 2.31B | -1.09% |
Apr 8, 2024 | 2.34B | 2.58% |
Apr 5, 2024 | 2.28B | 4.37% |
Apr 4, 2024 | 2.18B | 3.23% |
Apr 3, 2024 | 2.11B | -3.41% |
Apr 2, 2024 | 2.19B | -1.22% |
Apr 1, 2024 | 2.21B | 1.38% |
Mar 28, 2024 | 2.18B | 9.04% |
Mar 27, 2024 | 2.00B | - |
Mar 26, 2024 | 2.00B | 1.37% |
Mar 25, 2024 | 1.98B | -5.83% |
Mar 22, 2024 | 2.10B | -5.51% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ardelyx | 1.49B |
Protagonist Therapeutics | 1.47B |
Dynavax Technologies | 1.46B |
LeMaitre Vascular | 1.46B |
Gyre Therapeutics | 1.46B |
InMode | 1.45B |
Veracyte | 1.45B |
Arcus Biosciences | 1.41B |